Sea sponge-derived drug could extend life for breast cancer patients

Eribulin, a drug originally created from a sea sponge, has been shown to extend life for up to 5 months in women with advanced triple negative breast cancer.

ANTI-METASTATIC AGENTS: NEW DRUG DEVELOPMENTS AND NATURAL PRODUCTS

Eribulin, A Drug Originally Developed In Sea Sponges Can Increase Survival In Women With Triple Negative

Applied Sciences, Free Full-Text

Sponges-The way you move – Our world under the waves

Biomolecules, Free Full-Text

Sea sponge-derived drug could extend life for breast cancer patients

Chemical structure of tunicate-derived drug trabectedin.

Compound isolated from sea sponge fights cancer cells

Therapeutic Application of Diverse Marine-derived Natural Products in Cancer Therapy